Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 5:2022:2653089.
doi: 10.1155/2022/2653089. eCollection 2022.

Molecular Characterization and Genotype-Phenotype Correlation of G6PD Mutations in Five Ethnicities of Northern Vietnam

Affiliations

Molecular Characterization and Genotype-Phenotype Correlation of G6PD Mutations in Five Ethnicities of Northern Vietnam

Thi Thao Ngo et al. Anemia. .

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzyme disorder and is caused by G6PD gene mutations. To date, more than 400 variants in the G6PD gene have been discovered, and about 160 identified variants are associated with a significant decrease in the G6PD enzyme activity. However, the molecular characterization and epidemiological study of G6PD deficiency are still limited in Vietnam. Therefore, we conducted this study to determine the G6PD variants among the Vietnamese populations and evaluate their correlation to G6PD enzyme activity. A total of 339 patients (302 males and 37 females) were enrolled in this study. The G6PD variants were identified by Sanger sequencing. Our results indicate that males are more severely deficient in G6PD than females. This enzyme activity in males (1.27 ± 1.06 IU/g·Hb) is significantly lower than in females (2.98 ± 1.57 IU/g·Hb) (p < 0.0001). The enzyme activity of the heterozygous-homozygous females and heterozygous females-hemizygous males was found to be significantly different (p < 0.05), which is interpreted due to random X-inactivation. For G6PD molecular characteristics, Viangchan (c.871G>A), Canton (c.1376G>T) and Kaiping (c.1388G>A) variants were the most dominant, accounting for 24.48%, 17.70%, and 22.42%, respectively, whereas the highest frequency of complex variants was observed in Viangchan/Silent with 20.35%. In terms of G6PD activity, the Union variant presented the lowest mean value (1.03 IU/g·Hb) compared to the other variants (p < 0.05). Computational analysis using Polyphen-2 tool investigated that all variants were relative to G6PD deficiency and separated the levels as benign and damaged. The result will establish effective methods to screen G6PD variants in Vietnam.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest regarding the publication of this article.

Figures

Figure 1
Figure 1
Comparative distribution of G6PD activity by genders and genotypes. Each dot represents the G6PD enzyme activity of each subject. (a) G6PD activities between males and females. (b) G6PD activities among genotypes in both males and females.
Figure 2
Figure 2
The prevalence and G6PD enzyme activity among Vietnamese ethnics. (a) The prevalence of G6PD deficiency among five different ethnicities. (b) Distribution of G6PD activities according to ethnic groups.
Figure 3
Figure 3
The electropherogram of G6PD variants. (a) Gaohe (c) 95A > G), (b) Orissa (c.131 C > G), (c) Quing Yan (c.392 G > T), (d) Valladolid (c.406 C > T), (e) NanKang (c.517 T > G), (f) Mediterranean (c.563 C > T), (g) Coimbra Shunde (c.592 C > T), (h) Viangchan (c.871 G > A), (i) Chinese-5 (c.1024 C > T), (j) Taiwan-2 (c.1330 G > A), (k) Union (c.1360 C > T), (l) Canton (c.1376 G > T), (m) Kaiping (c.1388 G > A), (n) Silent (c.1311 C > T), and (o) Canton/Kaiping (c.1376 G > T/c.1388 G > A).
Figure 4
Figure 4
Distribution of G6PD activities according to mutation types. Only variant groups in which there were ≥ 2 representatives are shown. (a) G6PD activities of single identified variants. (b) G6PD activities of compound variants.

Similar articles

Cited by

References

    1. Gómez-Manzo S., Marcial-Quino J., Vanoye-Carlo A., et al. Glucose-6-phosphate dehydrogenase: update and analysis of new mutations around the world. International Journal of Molecular Sciences . 2016;17(12):p. 2069. doi: 10.3390/ijms17122069. - DOI - PMC - PubMed
    1. Ong K. I. C., Kosugi H., Thoeun S., et al. Systematic review of the clinical manifestations of glucose-6-phosphate dehydrogenase deficiency in the Greater Mekong Subregion: implications for malaria elimination and beyond. BMJ Global Health . 2017;2(3) doi: 10.1136/bmjgh-2017-000415.e000415 - DOI - PMC - PubMed
    1. Belfield K. D., Tichy E. M. Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency. American Journal of Health-System Pharmacy . 2018;75(3):97–104. doi: 10.2146/ajhp160961. - DOI - PubMed
    1. Kaplan M., Hammerman C., Bhutani V. K. Parental education and the WHO neonatal G-6-PD screening program: a quarter century later. Journal of Perinatology . 2015;35(10):779–784. doi: 10.1038/jp.2015.77. - DOI - PubMed
    1. Boonyawat B., Phetthong T., Suksumek N., Traivaree C. Genotype-phenotype correlation of G6PD mutations among central Thai children with G6PD deficiency. Anemia . 2021;2021:7. doi: 10.1155/2021/6680925.6680925 - DOI - PMC - PubMed

LinkOut - more resources